visual analogue pain scale

视觉模拟疼痛量表
  • 文章类型: Journal Article
    在下腹部手术后的第一天报告了中度至重度的疼痛。没有研究比较腹横肌平面(TAP)阻滞与后椎板阻滞(RLB)在腹腔镜腹股沟疝手术中的术后疼痛缓解。
    在这个前景中,随机试验,美国麻醉医师协会(ASA)的42名男性患者的身体状况I和II,18-65岁,BMI<40kg/m2的患者在腹腔镜腹股沟疝手术后接受TAP或RLB。进行了标准的全身麻醉技术。患者被随机分为两组:单次TAP阻滞(I组)(n=21)或RLB(II组)(n=21),双侧20ml0.375%罗哌卡因。术后,静脉给予扑热息痛1g作为抢救镇痛。术后24小时累积视觉模拟评分(VAS)评分被认为是主要结果。
    术后24小时休息时的累积VAS评分,表示为平均值±S.D(95%CI),TAP阻滞组为3.54±3.04(2.16~4.93),RLB组为6.09±4.83(3.89~8.29).TAP阻滞组P值为0.112,运动VAS值为7.95±3.41(6.39~9.50[2.5~15.0]),而RLB组的P值为0.110,运动时的VAS值为10.83±5.51(8.32-13.34)。
    在接受TAP阻滞或RLB的患者中,术后24h运动时的累积疼痛评分相似。然而,术后18小时和24小时接受TAP阻滞的患者在休息和运动时的VAS评分降低。
    UNASSIGNED: Moderate-to-severe intensity pain is reported on the first day following lower abdominal surgery. No study has compared transversus abdominis plane (TAP) block with retrolaminar block (RLB) in laparoscopic inguinal hernia surgery for postoperative pain relief.
    UNASSIGNED: In this prospective, randomized trial, 42 male patients of American Society of Anesthesiologists (ASA) physical status I and II, aged 18-65 years, and having a BMI <40 kg/m2 received TAP or RLB following laparoscopic inguinal hernia surgery. A standard general anesthetic technique was performed. Patients were randomized into two groups: single-shot TAP block (group I) (n = 21) or the RLB (group II) (n = 21) with bilateral 20 ml of 0.375% ropivacaine. Postoperatively, IV paracetamol 1 g was administered as rescue analgesia. Postoperative cumulative Visual Analogue Scale (VAS) score 24 hours after surgery was considered as the primary outcome.
    UNASSIGNED: Postoperative cumulative VAS score at rest at 24 h, represented as mean ± S.D (95% CI), in the TAP block group was 3.54 ± 3.04 (2.16-4.93) and in the RLB group was 6.09 ± 4.83 (3.89-8.29). P value was 0.112 and VAS on movement was 7.95 ± 3.41 (6.39-9.50 [2.5-15.0]) in TAP block group, whereas P value was 0.110 and VAS on movement was 10.83 ± 5.51 (8.32-13.34) in the RLB group.
    UNASSIGNED: Similar postoperative cumulative pain score on movement at 24 h was present in patients receiving TAP block or RLB. However, VAS score at rest and on movement was reduced in patients receiving TAP block at 18 and 24 h postoperatively.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    疼痛强度评估量表在评估术后疼痛和指导管理方面很重要。不同的量表可以用于患者自我报告他们的疼痛,但是研究确定轻度之间的切点,中度和重度疼痛仅限于<1500例患者的研究.我们检查了913例患者在休息和活动时同时进行的13,017例急性术后疼痛评分,在手术后4小时至48小时之间,使用口头评定量表(没有,温和,中度或重度疼痛)和0-100毫米视觉模拟量表。我们在视觉模拟量表上确定轻度和中度疼痛之间的最佳切点为35mm,中度和重度疼痛为80毫米。这些对于休息和活动时的疼痛保持一致,随着时间的推移。我们还探讨了类别分歧的存在,定义为患者口头描述没有或轻度疼痛评分高于视觉模拟量表上的轻度/中度切点,和患者口头描述中度或重度疼痛评分低于视觉模拟量表上的轻度/中度切点。使用30和60mm切割点,1533个观测值(12%)显示类别分歧,并使用35和80毫米切割点,1632(13%)显示出类别分歧。大约八分之一的同时疼痛评分令人难以置信地不同意,可能导致不正确的疼痛报告。原因尚不清楚,但识字率和算术率低可能是促成因素。了解疼痛量表之间的这些分歧对于疼痛研究和医学实践很重要。
    Pain intensity assessment scales are important in evaluating postoperative pain and guiding management. Different scales can be used for patients to self-report their pain, but research determining cut points between mild, moderate and severe pain has been limited to studies with < 1500 patients. We examined 13,017 simultaneous acute postoperative pain ratings from 913 patients taken at rest and on activity, between 4 h and 48 h following surgery using both a verbal rating scale (no, mild, moderate or severe pain) and 0-100 mm visual analogue scale. We determined the best cut points on the visual analogue scale between mild and moderate pain as 35 mm, and moderate and severe pain as 80 mm. These remained consistent for pain at rest and on activity, and over time. We also explored the presence of category disagreements, defined as patients verbally describing no or mild pain scored above the mild/moderate cut point on the visual analogue scale, and patients verbally describing moderate or severe pain scored below the mild/moderate cut point on the visual analogue scale. Using 30 and 60 mm cut points, 1533 observations (12%) showed a category disagreement and using 35 and 80 mm cut points, 1632 (13%) showed a category disagreement. Around 1 in 8 simultaneous pain scores implausibly disagreed, possibly resulting in incorrect pain reporting. The reasons are not known but low rates of literacy and numeracy may be contributing factors. Understanding these disagreements between pain scales is important for pain research and medical practice.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    背景:大多数脊髓灰质炎患者从最初的感染中恢复,但发展为肌肉无力,15-40年后的疼痛和疲劳,一种叫做脊髓灰质炎后综合症的疾病。虽然脊髓灰质炎病毒已几乎被消灭,全世界仍有1200万至2000万人患有脊髓灰质炎后遗症。疼痛主要被描述为伤害性,但有些患者会出现神经性疼痛.这项研究的目的是进一步表征脊髓灰质炎后疼痛。
    方法:共有20名脊髓灰质炎后综合征患者参与了研究。进行了体格检查,完成了包含静息和运动时疼痛强度的疼痛绘图和视觉模拟评分(VAS)以及疲劳的VAS的问卷。进行步行测试以评估物理性能。
    结果:疼痛强度高(静息时VAS为42/100,移动时为62/100)。疼痛局限于关节和肌肉。肌肉疼痛是“深痛”的特征,包括“肌肉痉挛”,主要位于脊髓灰质炎弱化的四肢。
    结论:脊髓灰质炎后综合征患者的肌肉疼痛不符合伤害性或神经性疼痛的标准;因此,有人认为这种疼痛被称为“脊髓灰质炎后肌肉疼痛”。运动时小儿麻痹症后肌肉疼痛的强度更高,但不影响身体机能,与疲劳是分开的。
    BACKGROUND: Most patients with polio recover from the initial infection, but develop muscle weakness, pain and fatigue after 15-40 years, a condition called post-polio syndrome. Although poliovirus has been almost eliminated, 12-20 million people worldwide still have polio sequelae. The pain is described mainly as nociceptive, but some patients experience neuropathic pain. The aim of this study was to further characterize post-polio pain.
    METHODS: A total of 20 patients with post-polio syndrome participated in the study. Physical examination was performed, and questionnaires containing pain drawing and visual analogue scales (VAS) for pain intensity during rest and motion and VAS for fatigue were completed. A walk test was performed to evaluate physical performance.
    RESULTS: Pain intensity was high (42/100 on the VAS at rest and 62/100 while moving). The pain was localized in both joints and muscles. Pain in the muscles was of \"deep aching\" character, included \"muscle cramps\" and was located mainly in polio-weakened limbs.
    CONCLUSIONS: Muscle pain in patients with post-polio syndrome does not fulfil the criteria for either nociceptive or neuropathic pain; thus, it is suggested that the pain is termed \"post-polio muscular pain\". The intensity of post-polio muscular pain is higher while moving, but does not influence physical function, and is separate from fatigue.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    暂无摘要。
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Sci-hub)

  • 文章类型: Journal Article
    背景:在全身阿片类药物难治性癌症相关疼痛中,鞘内(IT)施用吗啡可以是一种有用的策略。在临床实践中,IT吗啡通常与其他具有不同作用机制的药物联合使用,以获得协同镇痛作用。然而,关于IT联合治疗的疗效和安全性的讨论仍在进行中.这项观察性研究的目的是报告低剂量齐科诺肽的IT组合的效果,吗啡,和左布比卡因在终末期癌症难治性疼痛中的应用。
    方法:60名成年患者,21名女性和39名男性,参加了IT设备植入。平均疼痛强度视觉模拟评分(VASPI)评分为88±20mm。所有患者均从三联疗法开始:根据吗啡的等效日剂量为每位患者计算吗啡的初始IT剂量;使用400/1的口服/IT比率。对于ziconotide,开始采用标准的缓慢滴定方案,剂量为1.2μg/天,左旋布比卡因的初始剂量为3mg/天.
    结果:吗啡的初始平均剂量,ziconotide,左布比卡因为0.8±0.3毫克/天,1.2微克/天和3毫克/天,分别。在第2天,VASPI评分显着降低(49±17,p<0.001),并且这种显着的降低持续到56天(平均VASPI评分44±9,p<0.001),吗啡的平均剂量为2±1毫克/天,ziconotide2.8±1mcg/天,和左布比卡因3.8±2毫克/天。观察到非常少的不良反应(AE)。在整个研究期间,患者的满意度非常高。
    结论:我们的结果,在研究设计的范围内,建议齐科诺肽的IT组合,吗啡,和左旋布比卡因,在低剂量下,可以安全快速地控制难治性癌症疼痛,患者满意度高。
    BACKGROUND: In cancer-related pain refractory to systemic opioids, intrathecal (IT) administration of morphine can be a useful strategy. In clinical practice, IT morphine is usually combined with other drugs with different mechanisms of action, in order to obtain a synergistic analgesic effect. However, the discussion on efficacy and safety of IT combination therapy is still ongoing. The aim of this observational study was to report the effects of an IT combination of low doses of ziconotide, morphine, and levobupivacaine in end-stage cancer refractory pain.
    METHODS: Sixty adult patients, 21 females and 39 males, were enrolled to an IT device implant. The mean visual analogue scale of pain intensity (VASPI) score was 88 ± 20 mm. All patients started with a triple combination therapy: the initial IT dose of morphine was calculated for each patient based on the equivalent daily dose of morphine; an oral/IT ratio of 400/1 was used. For ziconotide, a standard slow titration schedule was started at 1.2 μg/day and the initial dose of levobupivacaine was 3 mg/day.
    RESULTS: The initial IT mean doses of morphine, ziconotide, and levobupivacaine were 0.8 ± 0.3 mg/day, 1.2 mcg/day and 3 mg/day, respectively. At day 2, a significant reduction in VASPI score was registered (49 ± 17, p < 0.001), and this significant reduction persisted at 56 days (mean VASPI score 44 ± 9, p < 0.001), with mean doses of morphine 2 ± 1 mg/day, ziconotide 2.8 ± 1 mcg/day, and levobupivacaine 3.8 ± 2 mg/day. Very few adverse effects (AEs) were observed. Patients\' satisfaction was very high during the entire study period.
    CONCLUSIONS: Our results, within the limit of the study design, suggest that the IT combination of ziconotide, morphine, and levobupivacaine, at low doses, allows safe and rapid control of refractory cancer pain, with high levels of patient satisfaction.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Sci-hub)

       PDF(Pubmed)

  • 文章类型: Journal Article
    Background: Recent work has indicated that acute experimental pain affects left-right discrimination latency. This phenomenon highlights an effect of pain on the cortex that may have significant clinical importance in the form of pain state assessment. However, to date only limited study has further qualified this effect. A more thorough understanding of the magnitude and characteristics of this phenomenon is needed to determine its potential clinical utility. Objective: This study aimed to closely replicate previous studies investigating response latency changes for left-right discrimination judgements as a result of acute experimental pain. Methods: Twenty-two right-handed participants (n = 11 female, n = 11 male) free from pain, analgesia use, pain-related conditions, upper limb trauma/conditions, visual impairment, and dyslexia took part in this study. Participants completed a hand left-right discrimination judgement task before, during, and after an experimental pain stimulus was delivered to each hand separately. Experimental pain was achieved using an intramuscular injection of hypertonic (5%) saline into the thenar eminence of the left and right hands. Mean response times for the left-right discrimination task were determined and compared for pain location (right, left), pain condition (before, during, after), and image laterality (right, left). Pain intensity was rated at 20 s intervals during each left-right discrimination task. Results: A main effect of pain condition (p = 0.028) confirmed that pain intensity was significantly higher in the \"during pain\" condition compared to the \"before pain\" and \"after pain\" conditions. A main effect of image laterality (p = 0.002) further showed that response latency for right-hand pain was significantly shorter compared to left-hand pain. No significant interaction between the factors pain location and image laterality (p = 0.086) was found. For right-hand pain, response latencies for the unaffected hand were, however, descriptively greater compared to the affected hand, and this was not the case for left-hand pain. Furthermore, no main effect of pain stimulus or of pain location on response times was found (p = 1.00 and p = 0.202, respectively). Conclusion: Our results were not consistent with previous hand left-right discrimination response latency results and may cast doubt on the attentional bias hypothesis that is currently considered to underpin response latency changes during acute experimental hand pain. Individual responses to pain, subsets of participants, and differing mental rotation strategies during the left-right discrimination task may have influenced the results.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Sci-hub)

  • 文章类型: Journal Article
    要点小腿深静脉血栓形成患者的管理仍存在争议。我们对安慰剂对照的LMWH随机临床试验进行了事后分析。纳入时使用视觉模拟量表评估疼痛,一个和六个星期。两臂之间的疼痛控制没有差异。总结:背景远端深静脉血栓形成(DVT)的最佳管理存在很大争议。唯一可用的安慰剂对照试验表明,抗凝治疗缺乏明显的益处。许多医生认为,除了预防血栓栓塞并发症,低分子肝素(LMWH)抗凝有可能改善疼痛控制.目的分析LMWH对远端深静脉血栓形成患者疼痛的影响。患者和方法两百五十二患者纳入多中心,安慰剂对照,LMWH在急性远端DVT患者中的随机临床试验,并要求他们在纳入时和每次就诊时对疼痛进行评分。使用视觉模拟疼痛量表(VAS)。结果一百三十名患者在治疗性纳曲肝素组中被随机分配,122名患者在安慰剂组中被随机分配。包含时的平均VAS值为4.6(标准偏差[SD]2.5),2.1(SD2.0)在1周时和0.4(SD1.2)在6周时。我们计算了在两个研究时间点可获得VAS的患者在纳入和1周之间的VAS个体差异。用治疗性纳他帕林(n=106)和安慰剂(n=109)治疗的患者平均VAS降低没有差异:-2.6(SD2.4)与1周后-2.3(SD2.0)和-4.4(SD2.8)与-4.0(SD2.4)6周后,分别。使用压迫袜与疼痛减轻有关。结论这些数据表明,与安慰剂相比,使用LMWH并不能改善急性远端DVT患者的疼痛控制。
    Essentials Management of patients with calf deep vein thrombosis remains controversial. We conducted a post-hoc analysis of a placebo controlled LMWH randomized clinical trial. Pain was assessed using visual analogue scale at inclusion, one and six weeks. There was no difference in pain control between the two arms. SUMMARY: Background The optimal management of distal deep vein thrombosis (DVT) is highly debated. The only available placebo-controlled trial suggested the absence of clear benefit of anticoagulation. Many physicians feel that, beyond preventing thromboembolic complications, anticoagulation with low-molecular-weight heparin (LMWH) has the potential to improve pain control. Objectives To analyze whether LMWHs decrease pain in patients with distal deep vein thrombosis. Patients and methods Two-hundred and fifty-two patients included in a multicenter, placebo-controlled, randomized clinical trial of LMWH in patients with acute distal DVT and who were asked to rate their pain at inclusion and at each medical visit, using a visual analogue pain scale (VAS). Results One hundred and thirty patients were randomized in the therapeutic nadroparin arm and 122 patients were randomized in the placebo arm. Mean VAS values were 4.6 (standard deviation [SD] 2.5) at inclusion, 2.1 (SD 2.0) at 1 week and 0.4 (SD 1.2) at 6 weeks. We calculated the individual variation in VAS between inclusion and 1 week in patients in whom VAS was available at the two study time-points. There was no difference in the mean VAS reduction between patients treated with therapeutic nadroparin (n = 106) and with placebo (n = 109): -2.6 (SD 2.4) vs. -2.3 (SD 2.0) after 1 week and -4.4 (SD 2.8) vs. -4.0 (SD 2.4) after 6 weeks, respectively. The use of compression stockings was associated with a reduction in pain. Conclusion These data suggests that LMWH use does not improve pain control as compared with placebo in patients with acute distal DVT.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Sci-hub)

  • 文章类型: Journal Article
    不管是急性还是慢性,疼痛的评估应该简单实用。由于疼痛的强度被认为是决定其对人类整体功能和感觉的影响的主要因素之一,有许多量表来评估疼痛。本文的目的是回顾牙科和口腔颌面外科(OMFS)中常用的疼痛强度量表。以前的研究表明,多维尺度,比如麦吉尔疼痛问卷,麦吉尔疼痛问卷的简短形式,威斯康星州简短疼痛问卷适用于评估慢性疼痛,而一维尺度,如视觉模拟量表(VAS),言语描述符量表,言语评定量表,数值评级量表,面对疼痛量表,Wong-Baker面部疼痛量表(WBS),和全杯测试,用于评估急性疼痛。WBS广泛用于评估儿童和老年人的疼痛,因为其他量表通常很难理解,这可能导致对疼痛强度的高估。在牙科或OMFS研究中,VAS的使用更普遍,因为它更可靠,有效,敏感,和适当的。然而,一些研究人员使用NRS评估成人OMFS疼痛,因为该量表比VAS更易于使用,且疼痛评分相对相似.本综述仅评估了用于术后OMFS或牙科疼痛的疼痛量表。
    Regardless of whether it is acute or chronic, the assessment of pain should be simple and practical. Since the intensity of pain is thought to be one of the primary factors that determine its effect on a human\'s overall function and sense, there are many scales to assess pain. The aim of the current article was to review pain intensity scales that are commonly used in dental and oral and maxillofacial surgery (OMFS). Previous studies demonstrated that multidimensional scales, such as the McGill Pain Questionnaire, Short form of the McGill Pain Questionnaire, and Wisconsin Brief Pain Questionnaire were suitable for assessing chronic pain, while unidimensional scales, like the Visual Analogue Scales (VAS), Verbal descriptor scale, Verbal rating scale, Numerical rating Scale, Faces Pain Scale, Wong-Baker Faces Pain Rating Scale (WBS), and Full Cup Test, were used to evaluate acute pain. The WBS is widely used to assess pain in children and elderly because other scales are often difficult to understand, which could consequently lead to an overestimation of the pain intensity. In dental or OMFS research, the use of the VAS is more common because it is more reliable, valid, sensitive, and appropriate. However, some researchers use NRS to evaluate OMFS pain in adults because this scale is easier to use than VAS and yields relatively similar pain scores. This review only assessed pain scales used for post-operative OMFS or dental pain.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Sci-hub)

  • 文章类型: Journal Article
    晚期强直性脊柱炎通常与胸腰椎后凸有关,导致脊柱骨盆平衡和骨盆形态异常。不同的截骨技术已被用于矫正AS畸形,不幸的是,并非所有AS患者在截骨后都能获得脊柱矢状面平衡和良好的水平视力。
    回顾性研究了14例接受两级PSO治疗的严重胸腰椎后凸的AS患者。全部为男性,平均年龄34.9±9.6岁。随访1-5年。使用Surgimap脊柱软件对所有患者进行术前计算机模拟,从计算机模拟中确定的截骨水平和角度被用于手术。术前测量脊柱矢状面参数,在计算机模拟之后,术后包括胸椎后凸畸形(TK),腰椎前凸(LL),矢状垂直轴(SVA),骨盆发病率,骨盆倾斜(PT),和骶骨斜率(SS)。评估了计算机模拟与术后参数之间的相关性水平,并比较术前、术后参数的差异。还评估了背痛和临床结果的视觉模拟量表(VAS)。
    6例在L1和L3行PSO,5例在L2和T12行PSO,3例在L3和T12行PSO。TK由术前57.8±15.2°校正至术后45.3±7.7°(P<0.05),LL从9.3±17.5°到-52.3±3.9°(P<0.001),SVA从154.5±36.7到37.8±8.4mm(P<0.001),PT从43.3±6.1°到18.0±0.9°(P<0.001),SS由0.8±7.0°降至26.5±10.6°(P<0.001)。LL,VAS,模拟的两级PSO的PT与,或者几乎一样,术后参数。计算机模拟与术后参数之间的相关性显着。VAS从6.1±1.9显著降低至2.0±1.1(P<0.001)。就临床结果而言,10例“优”级,4例“良”级。\"
    使用术前计算机模拟的两级PSO是可行的,安全,是治疗颈椎运动正常的AS患者严重胸腰椎后凸畸形的有效技术。
    UNASSIGNED: Advanced ankylosing spondylitis is often associated with thoracolumbar kyphosis, resulting in an abnormal spinopelvic balance and pelvic morphology. Different osteotomy techniques have been used to correct AS deformities, unfortunnaly, not all AS patients can gain spinal sagittal balance and good horizontal vision after osteotomy.
    UNASSIGNED: Fourteen consecutive AS patients with severe thoracolumbar kyphosis who were treated with two-level PSO were studied retrospectively. All were male with a mean age of 34.9 ± 9.6 years. The followup ranged from 1-5 years. Preoperative computer simulations using the Surgimap Spinal software were performed for all patients, and the osteotomy level and angle determined from the computer simulation were used surgically. Spinal sagittal parameters were measured preoperatively, after the computer simulation, and postoperatively and included thoracic kyphosis (TK), lumbar lordosis (LL), sagittal vertical axis (SVA), pelvic incidence, pelvic tilt (PT), and sacral slope (SS). The level of correlation between the computer simulation and postoperative parameters was evaluated, and the differences between preoperative and postoperative parameters were compared. The visual analog scale (VAS) for back pain and clinical outcome was also assessed.
    UNASSIGNED: Six cases underwent PSO at L1 and L3, five cases at L2 and T12, and three cases at L3 and T12. TK was corrected from 57.8 ± 15.2° preoperatively to 45.3 ± 7.7° postoperatively (P < 0.05), LL from 9.3 ± 17.5° to -52.3 ± 3.9° (P < 0.001), SVA from 154.5 ± 36.7 to 37.8 ± 8.4 mm (P < 0.001), PT from 43.3 ± 6.1° to 18.0 ± 0.9° (P < 0.001), and SS from 0.8 ± 7.0° to 26.5 ± 10.6° (P < 0.001). The LL, VAS, and PT of the simulated two-level PSO were highly consistent with, or almost the same as, the postoperative parameters. The correlations between the computer simulations and postoperative parameters were significant. The VAS decreased significantly from 6.1 ± 1.9 to 2.0 ± 1.1 (P < 0.001). In terms of clinical outcome, 10 cases were graded \"excellent\" and 4 cases were graded \"good.\"
    UNASSIGNED: Two-level PSO using a preoperative computer simulation is a feasible, safe, and effective technique for the treatment of severe thoracolumbar kyphosis in AS patients with normal cervical motion.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    目的:比较奥美拉唑联合多潘立酮与奥美拉唑单药治疗胃食管反流病(GERD)的疗效和安全性。
    方法:在比较中,随机对照,第四阶段研究,GERD门诊患者按等比例随机分为第1组(奥美拉唑20mg+多潘立酮30mg)或第2组(奥美拉唑20mg);每天早晨给药2粒,共8周.
    结果:纳入60例患者。在第1组92%的患者中观察到食管炎逆转,在第2组中观察到65.2%。大约,第1组83.3%的患者与第2组43.3%的患者在第8周时表现出完全拔罐的反流症状。联合治疗导致无胃灼热天数明显延长(奥美拉唑治疗23天vs12天)。没有安全问题。
    结论:奥美拉唑-多潘立酮联合用药在GERD患者的反流症状完全拔罐和食管炎愈合方面比奥美拉唑单独用药更有效。两种治疗均具有良好的耐受性,很少有不良事件报告。
    背景:此试验已在http://clinicaltrials.gov注册,编号NCT02140073。
    OBJECTIVE: To compare the efficacy and safety of omeprazole-domperidone combination vs omeprazole monotherapy in gastroesophageal reflux disease (GERD).
    METHODS: In a comparative, randomized controlled, phase 4 study, outpatients with GERD were randomly allocated to either group 1 (omeprazole 20 mg + domperidone 30 mg) or group 2 (omeprazole 20 mg) in an equal ratio; 2 capsules daily in the morning were administered for 8 weeks.
    RESULTS: Sixty patients were enrolled. Esophagitis reversal was observed in 92% patients in group 1 vs 65.2% in group 2. Approximately, 83.3% patients in group 1 vs 43.3% patients in group 2 demonstrated full cupping of reflux symptoms at 8 weeks. Combined therapy resulted in significantly longer period of heartburn-free days (23 vs 12 days on omeprazole). There were no safety concerns.
    CONCLUSIONS: Omeprazole-domperidone combination was more effective than omeprazole alone in providing complete cupping of reflux symptoms and healing of esophagitis in patients with GERD. Both the treatments were well tolerated with few reports of adverse events.
    BACKGROUND: This trial is registered with http://clinicaltrials.gov, number NCT02140073.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Sci-hub)

       PDF(Pubmed)

公众号